References

  1. VALCHLOR [package insert]. South San Francisco, CA: Actelion Pharmaceuticals US, Inc.; 2016.
  2. Lymphoma Research Foundation. Cutaneous T-cell lymphoma. http://www.lymphoma.org. Accessed December 13, 2016.
  3. Leukemia & Lymphoma Society. Cutaneous T-cell lymphoma facts. http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/lymphoma/pdf/cutaneoustcelllymphoma.pdf. Revised June 2014. Accessed December 13, 2016.
  4. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for T-cell Lymphomas V2.2017. © 2017 National Comprehensive Cancer Network, Inc. All rights reserved. Accessed March 21, 2017. To view the most recent and complete version of the guideline, go online to www.nccn.org. NATIONAL COMPREHENSIVE CANCER NETWORK®, NCCN®, NCCN GUIDELINES®, and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc.
  5. Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal. J Clin Oncol. 2010;28:4730-4739.